Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
$0.08
$0.09
$0.04
$0.10
N/AN/A14,221 shsN/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
0.00%0.00%-9.68%+1.82%-9.85%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
N/A-$0.43N/AN/AN/AN/AN/A5/12/2024 (Estimated)

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
40.26%

Insider Ownership

CompanyInsider Ownership
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Vycor Medical, Inc. stock logo
VYCO
Vycor Medical
6N/AN/ANot Optionable

VYCO and ADR Headlines

SourceHeadline
BlueChew Review 2024BlueChew Review 2024
medicalnewstoday.com - January 17 at 6:44 PM
What to know about bleeding hemorrhoidsWhat to know about bleeding hemorrhoids
medicalnewstoday.com - December 19 at 8:43 AM
Common symptoms of depression: What to knowCommon symptoms of depression: What to know
medicalnewstoday.com - October 11 at 10:44 PM
Vycor Medical, Inc. (VYCO)Vycor Medical, Inc. (VYCO)
finance.yahoo.com - January 7 at 6:28 PM
Medical Review BoardMedical Review Board
health.usnews.com - November 1 at 6:14 PM
Medical Scholars ProgramMedical Scholars Program
slu.edu - September 12 at 10:45 AM
Vycor Medical IncVycor Medical Inc
reuters.com - September 8 at 10:15 AM
Minnetronix commercializes its own product: a minimally invasive deep brain access portMinnetronix commercializes its own product: a minimally invasive deep brain access port
medcitynews.com - August 20 at 1:18 AM
ViewSite Brain Access System (VBAS) for the surgical management of deep brain lesionsViewSite Brain Access System (VBAS) for the surgical management of deep brain lesions
nice.org.uk - May 12 at 12:34 AM
Vycor Medical Year to Date Total Returns (Daily)Vycor Medical Year to Date Total Returns (Daily)
ycharts.com - January 2 at 10:20 AM
Vycor Medical Inc (VYCO)Vycor Medical Inc (VYCO)
nasdaq.com - December 17 at 11:51 PM
The journal of physical chemistry. BThe journal of physical chemistry. B
medscape.com - October 18 at 10:40 PM

Media Sentiment Over Time

Company Descriptions

Vycor Medical logo

Vycor Medical

OTCMKTS:VYCO
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates in two segments, Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. Vycor Medical, Inc. has a license and transition agreement with HelferApp GmbH, which grants HelferApp the license to provide NovaVision's products and therapies to patients and professionals in Austria and Switzerland. The company primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.